Idiopathic pulmonary fibrosis (IPF) is a chronic lung disorder with a low survival rate. Pulmonary fibrosis is one of the complications of COVID-19 and has a high prevalence in COVID-19 patients. Currently. no effective therapies other than lung transplantation are available to cure IPF and post-COVID-19 pulmonary fibrosis. https://www.chiggate.com/